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Summary
y/b T cells have recently been described in association with a number of disorders, including
autoimmune diseases. y/b T cells are thought to play a cytotoxic role, but their mechanism
ofaction is not known. Several granule mediators ofcytotoxicity, including a pore-forming protein
(perforin), and a family ofserine esterases, have been isolated from cytotoxic T lymphocytes (CTL),
lymphokine-activated killer(LAK) cells, and natural killer (NK) cells. We demonstrate here that
y/b T cells also express these mediators . Northern blots show that y/bT cells express perforin,
serine esterase 1 (SE 1), and SE 2 . Three polyclonal antisera-raised against murine perforin,
a peptide composed of amino acids 1-34 of human perforin, and human perforin expressed in
bacteria-all reacted with a 70-kD protein in y/b T cells on Western blots. Immunostaining
with antiperforin antisera shows that primary y/S T cells also contain perforin. Electron microscopy
reveals that the granules of y/b T cells resemble those of CTL, LAK, and NK cells . y/b T
cells also resemble LAK cells in possessing inclusion bodies in their nuclei . These results imply
that y/b T cells resemble other cytolytic lymphocytes in their mechanism of action .
C
ells with y/b TCRs (y/bT cells) generallyexhibitMHC-
unrestricted cytotoxicity in vitro. Target cells recognized
by y/b T cells are markedly different from those recognized
by CTL and by NK cells (1), suggesting that y/b T cells
are a previously unrecognized type of killer lymphocyte . y/b
T cells react withboth the mycobacterial and themammalian
65-kD heat shock protein (HSP65) ; this crossreactivity may
be important in the pathogenesis of autoimmune diseases,
including rheumatoid arthritis (RA) (2-4) . The cytotoxic
mechanisms of y/b T cells are not known, although several
mediators ofcytoto icity have been described in other cyto-
lytic lymphocytes (5-8). These mediators, present in the
granules ofCTL, NK cells, and lymphokine-activated killer
(LAK) cells, include a pore-forming protein (PFP ; perforin,
cytolysin), serine esterase 1 (SE 1 ; Hanukah Factor, granzyme
A), and SE 2 (granzyme B) . We used Northern blots, im-
munoblots, and immunostaining to determine whether y/b
T cells also contain these cytotoxic mediators.
Cells. Human y/b T cell clones 1.2, 1.3, 1.4, and 4 .1 (all
TCRct/,Q- , -y/b', CD3*, CD4- , CD8 - ) were derived from the
synovial fluid ofa patient withRA as described (2) . y chaincDNA
sequencing data showed common use of V.,9Jp rearrangements
with junctional diversity among clones, suggesting that the four
clones were distinct clonal populations (Loh, E ., J. Holoshitz, and
S. Strober, manuscript in preparation) . Human LAK cells were pre-
pared by stimulating plastic nonadherentPBMC for 10 d with 1,000
U/ml of rIIr2 (Cetus Corp., Emeryville, CA) . Human peripheral
blood NK cells stimulated with 11,2 were generously provided by
Dr. Bice Perussia (Wistar Institute, Philadelphia, PA) .
Cytotoxicity Assays.
￿
Standard 4-h "Cr release assays (9) were
performed using tumor lines K562, Daudi, and autologous (1BEB)
or heterologous (DSEB) EBVtransformed B cell lines as targets .
cDNA Probes and Northern Blot Analysis.
￿
"P-labeled cDNA
probes specific for perforin, SE 1, SE 2, and y-actin were prepared
and hybridized sequentially with total RNA blots on nylon mem-
branes as described (9) .
Antibodies andImmunoblt Analysis.
￿
Rabbit polyclonal antiper-
forin antisera were generated against purified mouse perforin (10),
human perforin expressed in bacteria (11), and against a synthetic
peptide (pNI-34) composed of amino acids 1-34 of human per-
forin . The peptide was immobilized on nitrocellulose, mixed with
Freund's adjuvant, and 10-15 wg was injected subcutaneously into
rabbits ; five booster injections were given . Immunoblotting was
done exactly as described (9) .
Immunostaining. CD4- , CD8- plastic nonadherent PBMC
selected by panning were cultured for 3 d with 500 U/ml of rlI.2
(12), stained with TCR-61 mAb (T Cell Sciences, Cambridge,MA)
and sorted using a FACStar® (Becton Dickinson & Co ., Mountain
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97% pure on FACS analysis . Primary y/6 T cells were cytocen-
trifuged, and stained sequentially with antiperforin antiserum and
FITC-conjugated goat anti-rabbit IgG (Fab')2 (Tago Inc., Burlin-
game, CA) .
Electron Microscopy .
￿
Clone 1.4 cells were fixed with an equal
volume of4% glutaraldehyde and 2% paraformaldehyde in 0 .1 M
cacodylate buffer, pH 7.2, postfixed with 2% OS04, dehydrated
in a graded ethanol series, and embedded in Epon 812 . Ultra-thin
sections stained with uranyl acetate and lead citrate were examined
in an electron microscope .
Results and Discussion
Cytotoxicity ofy/6 T Cells.
￿
y/b T cell clones displayed
MHC-unrestricted cytotoxicity against both NK-resistant
(Daudi) and NK-sensitive (K562) target cell lines (Fig . 1) .
However, no cytolytic activity could be found with autolo-
gous or heterologous EBVtransformed B cell lines (Fig . 1),
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Figure 1 .
￿
Cytotoxicity of 1'/6
T cells. y/6Tcells were tested for
cytolytic activity on s'Cr-labeled
tumor lines Daudi (open circles),
K562 (open triangles), and on two
M-transformed B cell lines :
JBEB (autologous ; closed circles)
and DSEB (heterologous; closed tri-
angles) .
Figure 2 .
￿
Expression of perforin, SE 1, and SE 2 by 'y/6 T cells. (a)
Northern blot analysis of total RNA from human LAK cells (lane 1),
y/6 T cells (lane 2), and Daudi cells (lane 3) withcDNA probes specific
for perforin, SE 1, SE 2, and actin . (b) Immunoblot analysis of human
NK cells (lanes 1, 4, and 8), y/6 T cells (lanes 2, 5, and 7), CTLIrR8
(lane 3), and K562 (lanes 6 and 9), with preimmune serum (lanes 1 and
2), antiserum raised against perforin expressed in bacteria (lanes 3-6), and
antiserum raised against an NH2-terminal peptide of human perforin
(lanes 7-9).
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suggesting that the cytolytic activity of these cells was an-
tigen specific and MHC independent .
7/6 T Cells Express Perform andSerineEsterases.
￿
Northern
blots of y/6 T cell clones (Fig . 2 a ; data shown for clone
1.4) showed that they expressed mRNAs for perforin, SE
1, SE 2, and actin. The size of the expressed messages was
the same as that seen in human LAK cells used as a control
(12) . Daudi cells (Fig . 2 a) and a panel of tumor cell lines
(not shown ; see reference 12) did not express mRNAs for
perforin or SEs.
These results were further confirmed by immunoblot anal-
ysis (Fig. 2 b) using three perforin-specific antisera raised against
human perforin expressed in Escherichia coli, a peptide com-
posed of amino acids 1-34 ofhuman perforin, and purified
murine perforin (not shown) . All three antisera reacted
specifically with human NK cells, CTLI7R8, and all four
clones of y/6 T cells (data shown only for clone 1.4) ; but
not withK562 cells, or YAC-1 cells (not shown) . Pre-immune
antisera did not react with any of the cell lysates tested . To
establish the presence of perforin in primary y/6 T cells, we
used immunostaining of a FACS-sorted population that was
97% pure. As seen in Fig . 3, primary y/6 T cells stained
with antiperforin antisera showed a granular pattern similar
to that seen with CTL andNK cells . Three independent lines
of evidence (Northern blots, Western blots with three an-
tisera raised against different forms of perforin, and immu-
nostaining of primary y/6T cells with anti-perforin antisera)
all suggest that y/6T cells express perforin . Perforin has now
been shown to be produced by all cytotoxic effector lympho-
cytes . Our results, obtained with clonal and primary cell popu-
lations, are the first definitive study reporting perforin ex-
pression in y/6 T cells.
Figure 3 .
￿
Immunofluorescence staining of primary 'y/6 T cells using
antiperforin antibody. Primary y/6 T cells, enriched by cell sorting (97%
pure), were stained with preimmune serum (b) or with antiperforin an-
tiserum (d) . Corresponding phase contrast micrographs are shown in a
and c .Figure 4.
￿
(a) Ultrastructure ofa y/b T cell . The large arrow indicates
an inclusion body in the nucleus. Small arrows show cytoplasmic granules
(x10,000) . Inset demonstrates a typical inclusion body, composed of
membrane-like structures and electron-dense particles. (b) High mag-
nification ofcytoplasmic granules. The granules are bound by a single mem-
brane and contain the dense cores with numerous surrounding vesicles
(x23,000) .
Ultrastructure ofy/S T Cells.
￿
y/6 T cells possess long
microvilli, well-developed mitochondria, elongated rough en-
doplasmic reticulum, and 100-160-nm granules surrounded
by a single membrane (Fig . 4, a and b) . The granules are com-
posed of a central core of electron-dense fine material sur-
rounded by numerous membrane-bound vesicles and resemble
those seen in CTL and NK cells . The nuclei are irregular
and are rich in chromatin concentrated near the nuclearmem-
brane. Many nuclei contain one ortwo inclusion bodies (IB)
that consist ofmembrane-like structures, electron-dense par-
ticles, and free ribosomes bound by a double membrane com-
plex (Fig. 3 a, inset) . Similar IB were found recently inhuman
LAK cells by Groscurth et al . (13). They suggest that the
IB are derived from endoplasmic reticulum, contain glycogen,
and represent overstimulation ofLAK cells with 1172 . As LAK
cells are a heterogenous population that includes y/6 T cells
(14), it is possible that IB are specifically associated with y/6
T cells. We are attempting to resolve this issue using immu-
noelectron microscopy ofLAK cells with antiTCR-y/6 an-
tibodies .
y/6 T cells may be implicated in RA and other autoim-
mune diseases. InRA patients, large numbers ofy/6T cells
are found in the synovial fluid of affectedjoints (2, 4) . This
observation, together with our finding thaty/6 T cells con-
tain perforin and SEs, suggests the possibility that y/6 T
cell-mediated destruction ofjoint tissue is of importance in
the pathology ofRA . Increased numbers of y/6 T cells are
also seen in pulmonary sarcoidosis (15), ataxia-telangiectasia
(16), leprosy and leishmaniasis (17), atopic dermatitis (18),
and Chediak-Higashi syndrome (19), suggesting that y/6T
cells play a role in a number of immunologic disorders.
A significant role for granule mediators in cell killing is
supported by the fact that antigenic or mitogenic signals
known to induce cytotoxic effectors also induce mRNAs for
perforin and SEs in T cells (12, 20) . The present results there-
fore strongly support the inclusion ofy/6T cells along with
CTL, NK, and LAK cells as cytolytic lymphocytes .
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